Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Do historical HbA1c values explain glycemic legacy effect in type 2 diabetes?

Do historical HbA1c values explain glycemic legacy effect in type 2 diabetes?

T1DM Mini-Series: Clinical implications of having hyperglycaemia with ketosis

T1DM Mini-Series: Clinical implications of having hyperglycaemia with ketosis

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

The superiority of Biologics over OCS for disease modifying potential which explains the superiority over OCS as anti-inflammatory option for our patients with CRSwNP, when we prescribe the Biologicals, we prescribe them long term for chronic disease where we do believe that we do not only aim to reduce inflammation but also to have some disease modifying effects.

Diabetes Your Type: Testimonial by Dr. Bassam​

Diabetes Your Type: Testimonial by Dr. Bassam​

Low risk of VTE Following Early Pregnancy Loss in Pregnancies Conceived by IVF

Low risk of VTE Following Early Pregnancy Loss in Pregnancies Conceived by IVF

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

T1DM Mini-Series: Edition Junior trial results

T1DM Mini-Series: Edition Junior trial results

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Effectiveness of continuous glucose monitoring in adults with Type 2 diabetes treated with basal insulin

Effectiveness of continuous glucose monitoring in adults with Type 2 diabetes treated with basal insulin

Evaluation of lipid management following ACS

Evaluation of lipid management following ACS